Y Intercept (Hong Kong) LTD Guardant Health, Inc. Transaction History
Y Intercept (Hong Kong) LTD
- $1.44 Billion
- Q4 2024
A detailed history of Y Intercept (Hong Kong) LTD transactions in Guardant Health, Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 13,799 shares of GH stock, worth $605,086. This represents 0.03% of its overall portfolio holdings.
Number of Shares
13,799
Previous 11,936
15.61%
Holding current value
$605,086
Previous $273,000
54.21%
% of portfolio
0.03%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding GH
# of Institutions
348Shares Held
120MCall Options Held
793KPut Options Held
1.85M-
Vanguard Group Inc Valley Forge, PA12.1MShares$529 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$493 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.42MShares$281 Million8.64% of portfolio
-
Baillie Gifford & CO5.45MShares$239 Million0.13% of portfolio
-
Cadian Capital Management, LP New York, NY5.22MShares$229 Million9.25% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $4.48B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...